Fighting Alzheimer’s disease may require a shift in strategy—one that targets multiple processes at once instead of focusing on a single cause.

Alzheimer’s is now understood as a highly complex condition shaped by a combination of biological factors, aging, and overall health. This complexity helps explain why treatments aimed at just one target have largely fallen short, even though some newer drugs have shown modest success in slowing cognitive decline.

According to a recent review by Professor Yan-Jiang Wang and colleagues, Alzheimer’s develops through the interaction of several mechanisms, including amyloid-beta accumulation, Tau protein tangles, genetic predisposition, age-related changes, and systemic health issues. Because of this, researchers argue that tackling the disease effectively will require a coordinated, multi-target approach.

While amyloid-beta has long been the main focus of research, scientists are increasingly recognizing the importance of Tau-related damage, which contributes to neuron loss. Addressing both processes simultaneously may offer better outcomes.

Genetics also play a crucial role. The APOE ε4 variant remains the most well-known risk factor, but new genetic links are being discovered. Emerging technologies like CRISPR gene editing could one day help modify these risks at their source.

Aging itself is the strongest driver of Alzheimer’s, bringing changes such as cellular damage, mitochondrial decline, and DNA instability. New therapies aimed at clearing aging cells—known as senolytics—are being explored as a way to protect brain function.

In addition, whole-body health significantly influences disease progression. Conditions like insulin resistance, hypertension, and imbalances in gut microbiota may worsen Alzheimer’s. Researchers are now studying whether diabetes medications and gut-brain therapies could help counteract these effects. Overall, scientists are calling for a move away from narrow, single-target treatments toward integrated strategies that address the disease as a system. Advances in precision medicine and early biomarkers may also allow earlier and more personalized intervention.

Researchers believe that with a comprehensive approach, Alzheimer’s could eventually become a manageable—or even preventable—condition rather than an inevitable consequence of aging.